At the news
? BULLISHIMPACT 6/10 6-K filed May 15, 2026 at 15:55 ET
Dr. Reddy's launched its generic Semaglutide Injection in Canada on May 15, 2026, following Health Canada approval on April 28, 2026. The company is the first to receive approval for a generic semaglutide in Canada, which is also the first G7 country to authorize the product. This expands Dr. Reddy's GLP-1 portfolio and demonstrates its ability to rapidly commercialize complex peptides.
- Dr. Reddy's launched generic Semaglutide Injection in Canada on May 15, 2026.
- Health Canada Notice of Compliance (NOC) received on April 28, 2026.
- Dr. Reddy's is the first company to receive Health Canada approval for generic Semaglutide Injection.
- Canada is the first G7 country to grant market authorization for generic Semaglutide Injection.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access